Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Expands Testing Capabilities by Signing First Amendment to Abbott Distribution Agreement; Partners with Ellerca Health Inc to Support Patients’ Needs
Avricore Health signed the first amendment to its supplier distribution agreement between subsidiary HealthTab and Abbott The amendment adds to the agreement Abbott’s ID Now(TM) molecular testing device, which will bring in onsite testing and reporting capabilities for SARS-CoV-2 (Covid-19), RSV, Influenza A & B, and Strep Avricore also announced its partnership with Ellerca Health, which will see the companies use their respective technologies (Avricore’s HealthTab and Ellerca’s 360Care app) to support patient needs at community pharmacy level Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) recently made several key strides in its quest to become the world’s leader point-of-care technologies within…